Clinical Utility of Next-generation Sequencing in the Management of Myeloproliferative Neoplasms: A Single-Center Experience

Abstract. Although next-generation sequencing (NGS) has helped characterize the complex genomic landscape of myeloid malignancies, its clinical utility remains undefined. This has resulted in variable funding for NGS testing, limiting its accessibility. At our center, targeted sequencing (TAR-SEQ) u...

Szczegółowa specyfikacja

Opis bibliograficzny

Główni autorzy:	Waleed Alduaij, Caroline J. McNamara, Andre Schuh, Andrea Arruda, Mahadeo Sukhai, Nisha Kanwar, Mariam Thomas, Jay Spiegel, James A. Kennedy, Tracy Stockley, Hubert Tsui, Rebecca Devlin, Hassan Sibai, Dawn Maze, Aaron Schimmer, Karen Yee, Steven Chan, Suzanne Kamel-Reid, Vikas Gupta
Format:	Artigo
Język:	Inglês
Wydane:	Wiley 2018-06-01
Seria:	HemaSphere
Dostęp online:	http://journals.lww.com/10.1097/HS9.0000000000000044
Etykiety:	Dodaj etykietę Nie ma etykietki, Dołącz pierwszą etykiete!